CLXT Calyxt Inc

Price (delayed)

$5.39

Market cap

$26.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.49

Enterprise value

$39.1M

Calyxt, based in Roseville, Minnesota, is a technology company with a mission to deliver plant-based innovations for a better world. Founded in 2010, Calyxt uses its proprietary TALEN® gene editing ...

Highlights
The gross profit has soared by 186% year-on-year and by 6% since the previous quarter
CLXT's EPS is up by 46% year-on-year and by 6% since the previous quarter
The company's revenue has shrunk by 99% YoY but it rose by 6% QoQ
The equity has dropped by 82% year-on-year and by 63% since the previous quarter
The quick ratio has plunged by 77% from the previous quarter and by 74% YoY

Key stats

What are the main financial stats of CLXT
Market
Shares outstanding
4.97M
Market cap
$26.81M
Enterprise value
$39.1M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
9.98
Price to sales (P/S)
159.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
234.11
Earnings
Revenue
$167,000
EBIT
-$16.58M
EBITDA
-$14.93M
Free cash flow
-$16.31M
Per share
EPS
-$3.49
Free cash flow per share
-$3.3
Book value per share
$0.54
Revenue per share
$0.03
TBVPS
$4.11
Balance sheet
Total assets
$20.29M
Total liabilities
$17.62M
Debt
$14.34M
Equity
$2.67M
Working capital
-$1.63M
Liquidity
Debt to equity
5.38
Current ratio
0.61
Quick ratio
0.49
Net debt/EBITDA
-0.82
Margins
EBITDA margin
-8,937.1%
Gross margin
100%
Net margin
-9,979.6%
Operating margin
-12,421.6%
Efficiency
Return on assets
-65.7%
Return on equity
-205.1%
Return on invested capital
-56.3%
Return on capital employed
-103.1%
Return on sales
-9,925.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CLXT stock price

How has the Calyxt stock price performed over time
Intraday
10.91%
1 week
33.42%
1 month
87.15%
1 year
-84.77%
YTD
-63.46%
QTD
-84.15%

Financial performance

How have Calyxt's revenue and profit performed over time
Revenue
$167,000
Gross profit
$167,000
Operating income
-$20.74M
Net income
-$16.67M
Gross margin
100%
Net margin
-9,979.6%
The gross profit has soared by 186% year-on-year and by 6% since the previous quarter
The company's revenue has shrunk by 99% YoY but it rose by 6% QoQ
The net income has grown by 33% YoY
CLXT's operating income is up by 19% year-on-year and by 7% since the previous quarter

Growth

What is Calyxt's growth rate over time

Valuation

What is Calyxt stock price valuation
P/E
N/A
P/B
9.98
P/S
159.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
234.11
CLXT's EPS is up by 46% year-on-year and by 6% since the previous quarter
The P/B is 127% above the 5-year quarterly average of 4.4
The equity has dropped by 82% year-on-year and by 63% since the previous quarter
The company's revenue has shrunk by 99% YoY but it rose by 6% QoQ
The stock's price to sales (P/S) is 49% less than its 5-year quarterly average of 314.5

Efficiency

How efficient is Calyxt business performance
The ROE has contracted by 38% YoY and by 36% from the previous quarter
The ROIC has grown by 17% year-on-year and by 4.1% since the previous quarter
The ROA has contracted by 16% from the previous quarter and by 8% YoY
CLXT's return on sales is up by 7% since the previous quarter

Dividends

What is CLXT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLXT.

Financial health

How did Calyxt financials performed over time
The total assets is 15% more than the total liabilities
The quick ratio has plunged by 77% from the previous quarter and by 74% YoY
The current ratio has plunged by 76% from the previous quarter and by 69% YoY
CLXT's debt to equity has surged by 188% since the previous quarter
The equity has dropped by 82% year-on-year and by 63% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.